title: Surrogate endpoints: wishful thinking or reality?
authors.forename: Stuart G
authors.initials: SG
authors.lastname: Baker
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood*; D015986:Confounding Factors, Epidemiologic; D006801:Humans; D008297:Male; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000276:immunology*; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results
chemical_list: D015415:Biomarkers; D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen